FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments

Description

Electronic health records (EHRs) are an increasingly common source for populating risk models, but whether used to populate validated risk assessment models or to de-facto build risk prediction models, EHR data presents several challenges. The purpose of this study is to assess how the integration of patient generated health data (PGHD) and EHR data can generate more accurate risk prediction models, advance personalized cancer prevention, improve digital access to health data in an equitable manner, and advance policy goals for Patient Generated Health Data (PGHD) and EHR interoperability.

Conditions

Breast Cancer

Study Overview

Study Details

Study overview

Electronic health records (EHRs) are an increasingly common source for populating risk models, but whether used to populate validated risk assessment models or to de-facto build risk prediction models, EHR data presents several challenges. The purpose of this study is to assess how the integration of patient generated health data (PGHD) and EHR data can generate more accurate risk prediction models, advance personalized cancer prevention, improve digital access to health data in an equitable manner, and advance policy goals for Patient Generated Health Data (PGHD) and EHR interoperability.

Integrating EHR and Patient-generated Health Data for Breast Cancer Risk Assessment and Decision Support in a Diverse Multiethnic Population

FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments

Condition
Breast Cancer
Intervention / Treatment

-

Contacts and Locations

New York

Columbia University Irving Medical Center, New York, New York, United States, 10032

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Women, age 35-74 years
  • * High-risk defined as 5-year invasive breast cancer risk ≥1.7% or 10 risk ≥20% according to the BCSC or GAIL models
  • * English- or Spanish-speaking
  • * Able to sign informed consent.
  • * Women with a personal history of breast cancer
  • * Women who previously participated in a sub-study (Aim 1) of the awarded grant.

Ages Eligible for Study

35 Years to 74 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Columbia University,

Rita Kukafka, DrPH, MA, PRINCIPAL_INVESTIGATOR, Columbia University

Study Record Dates

2025-04-15